Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Aclidinium Bromide in COPD
NCT00868231Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aclidinium in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Mar 2009; status: completed.
02
Drugs
aclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00868231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868231.